Get started

XCUR

#XCURUSDT Breaks Free from the Past!💎Just a fortnight ago, #XCURUSDT broke free from the confining grip of a falling wedge pattern, accompanied by a powerful breakout above the 50 Simple Moving Average. This marked a pivotal moment, signaling a potential shift in the prevailing trend direction. But what transpired next is what truly sets the stage for an enthralling journey of growth and possibilities. 💎 After encountering initial resistance at $0.023, #Curate pushed through and closed above this level. And that's not all! The price then experienced a noteworthy correction and found support at the 61.8% Fibonacci retracement level. This bounce reaffirms the changing trend and strengthens our bullish expectations. 💎 Patience becomes paramount in this exhilarating chapter, Paradisers. We eagerly await the transformation of the $0.023 level into a staunch support, a milestone that will set our plans into motion. Exercise caution, for the possibility lingers that #XCUR may yet test the limits, flirting with the 61.8% Fibonacci support, which would regrettably invalidate our bullish outlook. But for as long as the price holds firm, the odds remain in favor of further upside potential. 💎 Our sights are set on the 38.2% Fibonacci resistance, a beacon of opportunity that aligns harmoniously with the downtrend trendline and a pivotal supply/demand zone forged through the crucible of time. Should this celestial rendezvous come to fruition, #XCUR could witness a staggering 90% surge in price! But heed our counsel, Paradisers, for a minor resistance awaits at $0.035, demanding our unwavering vigilance along the path to greatness. Stay tuned, Paradisers, as we delve deeper into the vibrant realm of #XCURUSDT, unearthing new possibilities and guiding you towards prosperity. The ParadiseTeam is here to accompany you on this thrilling journey! 🌴
Long
by MyCryptoParadise
Exicure (NASDAQ: $XCUR) Could Double Or More In Near-Term! 🎯Exicure, Inc., a clinical-stage biotechnology company, develops therapeutics for neurology, immuno-oncology, inflammatory diseases, and genetic disorders based on its proprietary spherical nucleic acid (SNA) technology. Its drug candidate includes cavrotolimod (AST-008) that is in a Phase 1b/2 clinical trials in patients with advanced solid tumors. The company is also developing XCUR-FXN, an SNA–based therapeutic candidate that is in preclinical trials for the treatment of Friedreich's ataxia; XCUR17, an SNA that targets the messenger RNA (mRNA) encoding interleukin 17 receptor alpha; and AST-005, an SNA targeting TNF for the treatment of mild to moderate psoriasis. It has a collaboration, option, and license agreement with Allergan Pharmaceuticals International Limited to develop SNA-based treatments for hair loss disorders; license and development agreement with DERMELIX, LLC to research, develop, and commercialize its technology for the treatment of netherton syndrome; and collaboration agreement with Ipsen S.A. to research, develop, and commercialize novel spherical nucleic acids for Huntington's disease and Angelman syndrome. The company was founded in 2011 and is headquartered in Chicago, Illinois.
NASDAQ:XCURLong
by RedHotStocks
Curate ( XCUR ) 300% Profit opportunity.Curate ( XCUR ) Current Price: 5.05usd Buy Zone: 4.80-5.20usd Sell Zone: TP1: 8usd TP2: 10usd TP3:20usd Error percent +-%5-10! Curate is the world's first gasless multichain NFT marketplace offering NFT auctions, minting as well a general physical goods marketplace, all of which is supported by blockchain technology. Curate provides a fairer and more transparent open marketplace by offering an industry low 4% seller commission for both marketplaces and provides buyers with zero fees when they use XCUR, curates native token, to purchase in-app. All buyers and sellers are also rewarded in XCUR on all transactions. All users experience zero gas fees on the marketplace! XCUR is the native utility token with the following use cases: Purchases on the marketplace Zero gas fees and no hidden fees Rewards to all buyers/sellers on every purchase Stake to accrue APY% Spent on partners and merchants i.e Travala.com, CoinPayments.net and many more such as Expedia and Viator. How Many XCUR Tokens Are There in Circulation? Curate minted 10M XCUR tokens in 2020. In December 2020, 15% of the supply was burnt bringing the total supply down to 8.5M. Circulating supply is currently 8,499,802 XCUR tokens. Who are the Team behind Curate? Curate is the brainchild of developer and CEO James Hakim who founded the project in Jan 2019. Along with co-director and CFO Moe Carrim, work began on the project which focused on creating a marketplace for fashion and clothing aimed at millennials who use cryptocurrency. Curate project became what is now, an all in one marketplace offering an NFT and physical/digital goods marketplace. Curate employs more than 25 staff, including developers with experience at Google, Amazon and Joom.
Long
by BarcinGokboru
$XCUR at a key level• 95% circulating supply (big yes). The majority of it(Over 60%) is with holders. • Good community following and engagement • 38m market cap in a growing space. Rank #586. If it makes the top 100 which is very much possible, will have a market cap of about 800m. 800/38= 21X. That's 21x given similar market conditions. • Low commission, gasless, multichain NFT marketplace • Clean UIU/UX • Good partnerships: Expedia, Shooping.io, travala, Viator • Token burns TA looks good, - Broke out of downtrend and laddering up - Origin level at 4.722. Break and retest is a good buy zone - Bullish Moving averages aka trend H/e, • RSI overbought • Lots of competition: Opensea, rarible, binance,etc Idea credit: Bitcoin Chris
Long
by ashainp
2
XCUR is back on the upswing!XCUR has been in a down trend since its highs of mid-April. Around the 5th of May we had three key indicators showing that the trend was reversing. The MACD, RSI, and price all took bullish turns at this time. Since then, XCUR has come back and tested the 50 day moving average and held the line nicely. Additionally, XCUR has some bullish news coming out over the rest of Q2 (also the release of an app). With alt-season around the corner, XCUR looks like a nice hidden gem to get into while the prices are still low. Please like, comment, and follow for more! Trade at your own risk
Long
by zsamochin
1